FDA Adverse Event Injury Summary report: N

INSIGNIA

MDR report key: 2163139 · Received July 15, 2011

Report

Report Number
2124215-2011-07745
Event Type
Injury
Date Received
July 15, 2011
Date of Event
April 21, 2011
Report Date
September 21, 2011
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
NVZ
PMA / PMN Number
D970003
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, A THOROUGH EVALUATION OF THE DEVICE WAS PERFORMED. A VISUAL INSPECTION OF THE DEVICE HEADER AND CASE NOTED NO ANOMALIES. THE DEVICE WAS THEN EXPOSED TO SIMULATED HEART LOAD CONDITIONS, AND THE PACING AND SENSING FUNCTIONS WERE TESTED. THE DEVICE OPERATED APPROPRIATELY, ACCORDING TO ITS PERFORMANCE SPECIFICATIONS, WITH NO INTERRUPTIONS IN THERAPY OUTPUT OR PROGRAMMER COMMUNICATION AT THE RETURNED PROGRAMMED SETTINGS. A SERIES OF ELECTRICAL TESTS WAS ALSO PERFORMED, AND AGAIN, NORMAL DEVICE FUNCTION WAS OBSERVED.

Additional Manufacturer Narrative · 1

AS OF TODAY, THE EXPLANTED PRODUCT HAS NOT BEEN RETURNED FOR ANALYSIS. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

THE DEVICE WAS RETURNED FOR ANALYSIS.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT WITH THIS RIGHT VENTRICULAR LEAD AND PACEMAKER REPORTED EXPERIENCING NEAR SYNCOPAL EPISODES. UPON INTERROGATION, OVERSENSING OF NOISE WAS NOTED. THE DEVICE WAS PROGRAMMED TO 10MV AND THE NOISE AND OVERSENSING CONTINUED. DURING THE SURGICAL PROCEDURE, THE LEAD WAS ABANDONED AND THE DEVICE WAS EXPLANTED. A NEW LEAD AND DEVICE WERE SUCCESSFULLY IMPLANTED. THERE WAS NO REPORT OF ADVERSE PATIENT EFFECTS DUE TO THE EXPLANT PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INSIGNIA IMPLANTABLE PULSE GENERATOR NVZ GUIDANT CRM CLONMEL IRELAND 1298

Patients

Seq Age Sex Outcome Treatment
1 55 YR Hospitalization| L| R 4474| S606| 4471| 4473| 1298